Effects of percutaneous endovascular angioplasty for severe stenosis or occlusion of subclavian artery.
Humans
Male
Female
Aged
Middle Aged
Aged, 80 and over
Subclavian Artery
/ surgery
Retrospective Studies
Stents
/ adverse effects
Treatment Outcome
Subclavian Steal Syndrome
/ therapy
Endovascular Procedures
/ methods
Angioplasty
/ methods
Constriction, Pathologic
/ therapy
Angioplasty, Balloon
/ methods
Arterial Occlusive Diseases
/ therapy
Balloon expansion
Occlusion
Percutaneous endovascular angioplasty
Severe subclavian artery stenosis ≥ 70%
Stent deployment
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
21 Jun 2024
21 Jun 2024
Historique:
received:
28
11
2023
accepted:
19
06
2024
medline:
22
6
2024
pubmed:
22
6
2024
entrez:
21
6
2024
Statut:
epublish
Résumé
To investigate the effect and safety of percutaneous endovascular angioplasty (PEA) with optional stenting for the treatment of severe stenosis or occlusion of subclavian artery, patients with severe stenosis ≥ 70% or occlusion of subclavian artery treated with PEA were retrospectively enrolled. The clinical data were analyzed. A total of 222 patients were retrospectively enrolled, including 151 males (68.0%) and 71 females (32.0%) aged 48-86 (mean 63.9 ± 9.0) years. Forty-seven (21.2%) patients had comorbidities. Subclavian artery stenosis ≥ 70% was present in 201 (90.5%) patients and complete subclavian occlusion in 21 (9.5%) cases. Angioplasty was successfully performed in all (100%) patients. Balloon-expandable stents were used in 190 (85.6%) cases, and self-expandable stents in 20 (9.0%) cases. Only 12 (5.4%) cases were treated with balloon dilation only. Among 210 patients treated with stent angioplasty, 71 (33.8% or 71/210) cases underwent balloon pre-dilation, 139 (66.2% or 139/210) had direct deployment of balloon-expandable stents, and 2 (1.0% or 2/210) experienced balloon post-dilation. Distal embolization protection devices were used in 5 (2.3% or 5/222) cases. Periprocedural complications occurred in 3 (1.4%) patients, including aortic dissection in 2 (0.9%) cases and right middle cerebral artery embolism in 1 (0.5%). No hemorrhage occurred. Among 182 (82.0%) patients with 6-month follow-up, restenosis > 70% occurred in 1 (0.5%) patient, and among 68 (30.6%) patients with 12-month follow-up, restenosis > 70% took place in 11 (16.2%) patients. Percutaneous endovascular angioplasty can be safely and efficiently performed for the treatment of severe stenosis ≥ 70% or occlusion of subclavian artery.
Identifiants
pubmed: 38906992
doi: 10.1038/s41598-024-65302-y
pii: 10.1038/s41598-024-65302-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
14290Subventions
Organisme : Funding: This study was supported by funding from Henan Center for Outstanding Overseas Scientists
ID : (No. GZS2022019).
Organisme : Funding: This study was supported by funding from Henan Center for Outstanding Overseas Scientists
ID : (No. GZS2022019).
Organisme : 2013 Project of the Center for Capacity Building and Continuing Education of the National Health Commission on Neurological and Minimally Invasive Interventions
ID : GWJJ2023100103
Informations de copyright
© 2024. The Author(s).
Références
Iared, W., Mourao, J. E., Puchnick, A., Soma, F. & Shigueoka, D. C. Angioplasty versus stenting for subclavian artery stenosis. Cochrane Database Syst. Rev. 2, CD008461 (2022).
pubmed: 35187653
Labropoulos, N., Nandivada, P. & Bekelis, K. Prevalence and impact of the subclavian steal syndrome. Ann. Surg. 252, 166–170 (2010).
doi: 10.1097/SLA.0b013e3181e3375a
pubmed: 20531004
Shadman, R. et al. Subclavian artery stenosis: Prevalence, risk factors, and association with cardiovascular diseases. J. Am. Coll. Cardiol. 44, 618–623 (2004).
doi: 10.1016/j.jacc.2004.04.044
pubmed: 15358030
Wrotniak, L. et al. Resolution of ischemic symptoms after percutaneous angioplasty for a symptomatic subclavian artery stenosis. J. Vasc. Surg. 64, 684–691 (2016).
doi: 10.1016/j.jvs.2016.04.031
pubmed: 27565589
Yamaguchi, K. et al. Subclavian artery-carotid artery bypass for subclavian artery or common carotid artery severe stenosis or occlusion. Neurol. Med. Chir. (Tokyo) 63, 221–227 (2023).
doi: 10.2176/jns-nmc.2022-0307
pubmed: 37005246
Shankar Kikkeri, N. & Nagalli, S. Subclavian Steal Syndrome. Treasure Island (FL) with ineligible companies. Disclosure: Shivaraj Nagalli declares no relevant financial relationships with ineligible companies (Statpearls, 2023).
Wenkel, M. et al. Long-term outcome of carotid-subclavian bypass in the management of coronary-subclavian steal syndrome. Vasc. Endovasc. Surg. https://doi.org/10.1177/15385744231186272 (2023).
doi: 10.1177/15385744231186272
Jahic, E., Avdagic, H., Iveljic, I. & Krdzalic, A. Percutaneous transluminal angioplasty of subclavian artery lesions. Med. Arch. 73, 28–31 (2019).
doi: 10.5455/medarh.2019.73.28-31
pubmed: 31097856
pmcid: 6445618
Yamamoto, N. et al. Percutaneous transluminal angioplasty and stenting using an aspiration catheter. J. Neuroendovasc. Ther. 16, 277–282 (2022).
doi: 10.5797/jnet.cr.2021-0030
pubmed: 37502231
Huang, C. C. et al. Percutaneous transluminal angioplasty and stenting of post-irradiated stenosis of subclavian artery: A matched case-control study. J. Neuroradiol. 51, 66–73 (2023).
doi: 10.1016/j.neurad.2023.06.004
pubmed: 37364746
Gill, H., Gill, H. S. & Kotha, V. Subclavian atherectomy and angioplasty for coronary subclavian steal syndrome post CABG. Radiol. Case Rep. 17, 1524–1527 (2022).
doi: 10.1016/j.radcr.2022.02.032
pubmed: 35282316
pmcid: 8904387
European Stroke, O. et al. Esc guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: The task force on the diagnosis and treatment of peripheral artery diseases of the European Society of Cardiology (ESC). Eur. Heart J. 32, 2851–2906 (2011).
doi: 10.1093/eurheartj/ehr211
Przewlocki, T. et al. Determinants of immediate and long-term results of subclavian and innominate artery angioplasty. Catheter. Cardiovasc. Interv. 67, 519–526 (2006).
doi: 10.1002/ccd.20695
pubmed: 16547924
Chatterjee, S., Nerella, N., Chakravarty, S. & Shani, J. Angioplasty alone versus angioplasty and stenting for subclavian artery stenosis—A systematic review and meta-analysis. Am. J. Ther. 20, 520–523 (2013).
doi: 10.1097/MJT.0b013e31822831d8
pubmed: 23344091
Gao, B. L. et al. Transradial stenting for carotid stenosis in patients with bovine type and type iii aortic arch: Experience in 28 patients. World Neurosurg. 111, e661–e667 (2018).
doi: 10.1016/j.wneu.2017.12.138
pubmed: 29294393
Shen, S. et al. Effect of aortic arch type on technical indicators in patients undergoing carotid artery stenting. J. Int. Med. Res. 47, 682–688 (2019).
doi: 10.1177/0300060518807604
pubmed: 30378455
Zhang, J. L., Tong, W., Lv, J. F. & Chi, L. X. Endovascular treatment and morphology typing of chronic ostial occlusion of the subclavian artery. Exp. Ther. Med. 13, 2022–2028 (2017).
doi: 10.3892/etm.2017.4203
pubmed: 28565803
pmcid: 5443266
Schillinger, M. et al. Outcome of conservative versus interventional treatment of subclavian artery stenosis. J. Endovasc. Ther. 9, 139–146 (2002).
doi: 10.1177/152660280200900201
pubmed: 12010091
Rogers, J. H. & Calhoun, R. F. 2nd. Diagnosis and management of subclavian artery stenosis prior to coronary artery bypass grafting in the current era. J. Card. Surg. 22, 20–25 (2007).
doi: 10.1111/j.1540-8191.2007.00332.x
pubmed: 17239206
Stone, P. A., Srivastiva, M., Campbell, J. E. & Mousa, A. Y. Diagnosis and treatment of subclavian artery occlusive disease. Expert Rev. Cardiovasc. Ther. 8, 1275–1282 (2010).
doi: 10.1586/erc.10.111
pubmed: 20828350
Benhammamia, M., Mazzaccaro, D., Ben Mrad, M., Denguir, R. & Nano, G. Endovascular and surgical management of subclavian artery occlusive disease: Early and long-term outcomes. Ann. Vasc. Surg. 66, 462–469 (2020).
doi: 10.1016/j.avsg.2019.11.041
pubmed: 31863950
Galyfos, G. C., Kakisis, I., Maltezos, C. & Geroulakos, G. Open versus endovascular treatment of subclavian artery atherosclerotic disease. J. Vasc. Surg. 69, 269–279 (2019).
doi: 10.1016/j.jvs.2018.07.028
pubmed: 30292607
Modarai, B. et al. Comparison of extra-anatomic bypass grafting with angioplasty for atherosclerotic disease of the supra-aortic trunks. Br. J. Surg. 91, 1453–1457 (2004).
doi: 10.1002/bjs.4751
pubmed: 15386319
Schneider, V. et al. Endovascular therapy of subclavian artery occlusive disease involving the vertebral artery origin. VASA 49, 205–213 (2020).
doi: 10.1024/0301-1526/a000842
pubmed: 31904303
Li, Y. et al. Endovascular stenting for atherosclerotic subclavian artery stenosis in patients with other craniocervical artery stenosis. J. Thromb. Thrombolysis 35, 107–114 (2013).
doi: 10.1007/s11239-012-0789-4
pubmed: 22872507
Duchman, K. R. et al. Operative time affects short-term complications in total joint arthroplasty. J. Arthroplast. 32, 1285–1291 (2017).
doi: 10.1016/j.arth.2016.12.003
Gomez-Hernandez, M. T., Forcada, C., Varela, G., Jimenez, M. F., Spanish Group of Video-Assisted Thoracic Surgery. Operating time: An independent and modifiable risk factor for short-term complications after video-thoracoscopic pulmonary lobectomy. Eur. J. Cardiothorac. Surg. 62, 503 (2022).
doi: 10.1093/ejcts/ezac503
de Angelis, P. et al. Operative time is associated with postoperative complications after pulmonary lobectomy. Ann. Surg. 278, e1259–e1266 (2022).
doi: 10.1097/SLA.0000000000005696
pubmed: 36066195